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The Nutrition Impact Symptoms (NIS) score detects malnutrition risk in patients admitted to 1 
nephrology wards. 2 
 3 
Abstract 4 
Background: Nutritional screening tools recommended for the general hospitalised population do not 5 
always adequately detect malnutrition risk in patients with kidney disease. This study assessed the 6 
validity and reliability of the Nutrition Impact Symptoms (NIS) score as a nutrition screening tool for 7 
hospitalised inpatients in nephrology wards.  8 
 9 
Methods: Nutritional status was classified using Subjective Global Assessment (SGA).  NIS scores 10 
were calculated from the total score of responses to questions assessing symptoms impacting upon 11 
nutritional status from the patient-generated SGA.  Concurrent validity of NIS score was assessed using 12 
a receiver operating characteristics curve to predict malnutrition risk against SGA.  Predictive validity 13 
was examined against length of hospital stay (LOS) and 30–day readmission using Poisson and logistic 14 
regression respectively.  Inter-rater reliability of NIS scoring between assessors was determined using 15 
intra-class correlation.  16 
 17 
Results: In 143 patients (90M; mean (SD) age 57.8 (15.8) years), malnutrition prevalence was 38% 18 
(54/143) using SGA (rating B/C). Predicting malnutrition risk with an NIS score of ≥3 had a 19 
sensitivity of 0.89 and a specificity of 0.65 (area under the curve = 0.81 [95% confidence interval (CI), 20 
0.74 - 0.88]). For each 1-point increase in NIS score, the model predicted a 1.9% rise in the risk of an 21 
increased LOS (p=0.002).  30-day readmission was not associated with NIS score.  Inter-rater reliability 22 
was moderate (mean difference =0.53; intra-class correlation coefficient = 0.74; 95% CI 0.57-0.85).  23 
 24 
Conclusions: NIS score is a valid stand-alone nutrition screening tool to identify malnutrition risk in 25 
nephrology inpatients, and is associated with length of hospital stay.  26 
 27 
  28 
2 
 
Introduction 29 
Malnutrition is a common complication of renal disease, particularly in the later stages of chronic 30 
kidney disease (CKD) (stages 3-5) (KDIGO, 2013). Studies demonstrate that over 50% of patients 31 
admitted to nephrology wards are malnourished (1, 2), and uraemia, acidosis, dialysis and comorbidities 32 
all impact upon food intake and nutritional status in patients with kidney disease (3, 4). Impaired 33 
nutritional status is associated with poor clinical outcomes, including increased morbidity, longer 34 
hospital stay, readmission, reduced quality of life and poorer survival (5-9).  35 
 36 
Nutritional screening is simple and efficient method of identifying those at risk of malnutrition, and 37 
screening in the hospital setting helps ensure that patients receive timely and effective treatment where 38 
needed (10, 11).  In the UK, the Malnutrition Universal Screening Tool (MUST), identifies between 19-39 
60% of hospitalised patients as at risk of malnutrition (10).  However, evidence suggests that MUST 40 
lacks sensitivity and identifies only those at the highest malnutrition risk in patients with kidney disease 41 
when compared to nutrition assessment with Subjective Global Assessment (SGA) (12).  Fluctuations 42 
in weight due to fluid retention masking undetected loss of tissue, may make detection or assessment of 43 
weight loss difficult; a factor which is essential for the accurate completion of MUST, and any other 44 
tool using BMI as a screening criteria (2). Other nutrition screening tools such as the Mini Nutrition 45 
Assessment and Malnutrition Screening Tool (MST) have also demonstrated little promise for use in 46 
patients with kidney damage (Afsar et al., 2006; Lawson et al., 2012). These findings are in agreement 47 
with the results of a systematic review reporting no single screening tool is appropriate for use in all 48 
hospitalised patients, and that future research should focus on trying to identify the most suitable 49 
screening tools for specific patient groups (13).  Research on renal specific nutrition screening tools has 50 
continued.  The renal nutrition screening toll (R-NST) was recently developed and tested for validity 51 
and feasibility (1).  The R-NST demonstrated high sensitivity and specificity against SGA, however, 52 
when introduced into clinical practice there was low uptake when used by nurses, attributed to the need 53 
to access information from electronic clinical information systems, and poor agreement for scoring 54 
between researchers and nurses (1).  Therefore, the need for a user friendly and valid nutrition 55 
screening tool for renal patients remains evident.  56 
 57 
The Nutrition Impact Symptoms (NIS) score (Table 1) is part of the patient-generated SGA (PG-SGA), 58 
a validated nutrition assessment tool initially developed for use in oncology and also validated in 59 
haemodialysis (14, 15).  Based on recent evidence supporting the efficacy of the NIS score as a 60 
nutrition screening tool for haemodialysis outpatients (16), and the high level of malnutrition with 61 
multiple aetiologies in patients admitted to nephrology wards, it is hypothesised that the NIS score may 62 
be a valid and reliable nutrition screening tool for renal inpatients on nephrology wards.  63 
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 64 
Methods 65 
A cross-sectional and observational validation study was conducted.  Patients over 18 years were 66 
considered eligible for inclusion in the study if they were admitted for a planned or unplanned/ 67 
emergency admission, under the care of a consultant nephrologist, to an acute renal unit consisting of 68 
two wards, and had been an inpatient for <4 days.  All patients meeting the inclusion criteria were 69 
approached to participate in the study, during 3 separate recruitment periods of 4-8 weeks, between 70 
July 2014 and April 2015, with different assessors for each period. Patients were introduced to the 71 
researcher by members of the clinical care team - either the patient's nurses, doctors or dietitian 72 
approached the patient to request permission for the researcher to inform the patient about the study.    73 
To maintain consistency, all researchers were trained in the study methods by the same trainer (HM), 74 
and reached competency standards for NIS score and SGA assessment prior to data collection.  75 
Patients were excluded if their total hospital stay was less than 24 hours, or were unable to provide 76 
informed consent.   77 
 78 
Ethical approval was granted by the National Research Ethics Service Committee London - City & 79 
East (reference number 15/LO/0204), and permission to use the PG-SGA (2015, v3.22.15; metric 80 
and non-metric version) was obtained from pt-global.org.  Patients who met the inclusion criteria 81 
were given verbal and written information about the study prior to providing written informed consent.   82 
Confidentiality was maintained by coding patient identifiable details on paper records and in secure 83 
password protected electronic documentation. 84 
 85 
Concurrent Validity  86 
To calculate the NIS score, patients were asked “Have you had any of the following problems that have 87 
kept you from eating enough during the past two weeks?”, followed by listing each NIS symptom in turn. 88 
The total NIS score was calculated by adding the scores for all symptoms identified positively by 89 
patients (Table 1).  Individual NIS were only scored positively if they affected food intake (14).  The 90 
SGA was completed at the same time using the standard method (12) and SGA global classifications 91 
were used to categorise nutritional status (A – well nourished, B - moderately malnourished and C - 92 
severely malnourished).  Patients identified as malnourished, with an SGA rating on B or C, were 93 
referred directly to the responsible clinical renal dietitian for further assessment and intervention.   94 
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The ability of the NIS score to identify malnutrition risk was assessed against the SGA global 95 
classification of nutritional status as the reference standard.  Specificity (true negative cases / [(true 96 
negative + false positive] cases), and sensitivity (true positive cases / [true positive + false negative] 97 
cases), of a range of NIS scores to detect malnutrition risk were determined. 98 
 99 
Table 1. Nutrition Impact Symptoms (NIS) score for symptoms impacting on food intake*. 100 
Score = 1 Score = 2 Score = 3 
• nausea 
• constipation 
• things taste funny or have 
no taste 
• dry mouth 
• smells bother me 
• feel full quickly 
• fatigue 
• other  
(e.g. depression, finances, 
dental issues)   
• mouth sores  
• problems swallowing 
 
• no appetite, just did not feel 
like eating 
• vomiting 
• diarrhoea  
• Pain: where? __________ 
*Adapted from the PG-SGA (2015, v3.22.15; metric and non-metric version) http://pt-global.org 101 
 102 
Predictive and Clinical Validity 103 
Predictive validity was evaluated against length of stay (LOS) and readmission to any ward in the same 104 
hospital within 30 days of discharge.  LOS was defined as the total number of days spent as an 105 
inpatient during the admission, calculated by subtracting the hospital admission date from the date of 106 
discharge.  Serum albumin and C-reactive protein (CRP) concentrations on admission were recorded 107 
for each patient and the Charlson Comorbidity Index score (17) was calculated using clinical history 108 
and demographic data from electronic patient records.  109 
 110 
Inter-Rater Reliability 111 
The reliability of the NIS score was determined by repeating the NIS score in a subgroup of study 112 
participants (n=43) using a second measurer (a dietitian, nurse or healthcare assistant), blinded to the 113 
initial scoring, to assess NIS score only.  The NIS score was repeated on the same day to ensure that 114 
conditions were comparable.  115 
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 116 
Data Analysis 117 
Statistical analysis was carried out using SPSS version 22 (IBM).  Sample size calculations were based 118 
on findings from pilot testing of the NIS tool.  With an expected prevalence of malnutrition at 50%, 119 
88% specificity and 80% sensitivity for NIS, and precision within 10% and type-1 error of 5%, 125 120 
patients were required in the study.  Normality of the data was assessed using histograms and the 121 
Shapiro–Wilk test of normality.  Results were considered significant at p<0.05 and 95% confidence 122 
intervals (CIs) were computed where applicable. Baseline characteristics between malnourished (SGA B 123 
or C) and well nourished (SGA A) patients were compared with chi-squared tests - or Fisher’s Exact 124 
test when needed - for categorical variables, and independent t-tests or Mann Whitney U tests for 125 
parametric and non-parametric continuous variables, respectively. 126 
 127 
To establish the optimal NIS cut off score maximising the sensitivity and specificity of the tool in 128 
determining malnutrition risk, a receiver operating characteristic (ROC) curve and contingency table 129 
was produced comparing the NIS score with the SGA global rating of nutritional status as the 130 
reference standard (where SGA A = well-nourished and SGA B or C = malnourished).  With the 131 
finalised risk categories, concurrent validity of the NIS score was examined against the SGA global 132 
rating of nutritional status to determine the sensitivity and specificity of the NIS score in identifying 133 
malnutrition risk using the contingency table.  The associations between NIS score and clinical 134 
morbidity indicators, CRP, albumin and Charlson score, were assessed with Spearman rank correlations.  135 
The relationship between all 4 indicators and LOS or 30-day readmission were examined using Poisson 136 
linear regression analysis and forward, stepwise logistic regression analysis, respectively.  Intra-class 137 
correlation tested the inter-rater reliability of the NIS score.   138 
 139 
Results 140 
Of the 178 potentially eligible patients, 143 patients were recruited to the study. Baseline characteristics 141 
are outlined in Table 2.  38% of patients were malnourished when classified by SGA (33% as SGA 142 
rating B and 5% classified as SGA rating C).  Albumin, CRP and NIS score were significantly different 143 
between well-nourished and malnourished patients, and malnourished patients had a greater proportion 144 
of emergency/ unplanned admissions, compared to those who were well nourished.  145 
 146 
Concurrent Validity 147 
Examination of the contingency table indicated that the concurrent validity of the NIS score was 148 
greatest at a score of ≥3, classifying 55% (79/143) of patients as at risk of malnutrition.  The area under 149 
the ROC curve (AUC) was 0.81 (95% CI 0.74 - 0.88), indicating good concurrent validity (13).  150 
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Sensitivity was 89% (true risk of malnutrition identified) and specificity was 65% (true no risk of 151 
malnutrition identified), compared to SGA. 152 
 153 
Table 2. Baseline characteristics of patients admitted to acute renal inpatient wards by nutritional status 154 
Variable  Well-Nourished 
SGA1 A 
Malnourished 
SGA B or C  
p 
N (%) 
Age (years), mean ± SD2 
Gender, n (%) 
    Male  
    Female  
Ethnicity, n (%) 
    White 
    Black 
    Other 
Albumin (g/L) mean ± SD 
CRP3 (mg/L), median (IQR) 
Charlson Score, mean ± SD 
Admission type, n (%) 
    Elective  
    Unplanned  
Kidney Damage, n (%) 
    CKD4 stages 1-2 
    CKD stages 3-4 
    CKD stage 5 
    Acute Kidney Injury 
Length of stay (days), median 
(IQR)5 
NIS6 score, median (IQR) 
89 (62%) 
57.4 ± 15.7 
 
55 (62%) 
34 (38%) 
 
33 (37%) 
33 (37%) 
23 (26%) 
38.3 ± 5.5 
9.7 (3.8 – 28.8) 
5.1 ± 2.3 
 
37 (42%) 
52 (58%) 
 
7( 8%) 
22 (60%) 
53 (24%) 
7 (8%) 
4 (2 - 8) 
1.0 (0 - 4) 
54 (38%) 
58.3 ± 16.0 
 
35 (65%) 
19 (35%) 
 
27 (50%) 
12 (22%) 
15 (28%) 
35.7 ± 6.3 
25.1 (8.0 – 93.5) 
5.2 ± 2.5 
 
11 (20%) 
 43 (80%) 
  
2 (4%) 
12 (22%) 
30 (56%) 
10 (18%) 
5 (3 - 11) 
7.0 (4 - 10) 
 
0.88 
 
0.7 
 
 
0.2 
 
 
0.0098 
0.0147 
0.68 
 
0.01 
 
 
0.29 
 
 
 
0.17 
<0.0017 
1. SGA, Subjective Global Assessment; 2. SD, standard deviation; 3. CRP, C-reactive protein; 4. CKD, chronic kidney 155 
disease; 5. IQR, interquartile range; 6. NIS, Nutrition Impact Symptoms; 7. Mann Whitney U test; 8. Independent t-test; 9. 156 
Fisher’s Exact test. 157 
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 158 
Predictive and Clinical Validity 159 
Using rank correlation, NIS score was associated with CRP (ρ= 0.22, p = 0.011), but not albumin or 160 
Charlson score.  In the Poisson regression model, all factors predicted an increased risk of longer LOS; 161 
lower serum albumin concentration on admission, higher CRP, higher NIS score and lower Charlson 162 
score (Table 3).  For each 1-point increase in NIS score, the model predicted a 1.9% rise in the risk of 163 
an increased LOS (p = 0.002).  Using the median NIS score of 7 for malnourished patients, the risk of 164 
a longer LOS increased by 13.3%.  31 (22%) patients were readmitted to the same hospital within 30-165 
days of discharge; 5 planned and 26 unplanned admissions.  Factors associated with 30-day readmission 166 
were initial unplanned admission, LOS and albumin (Table 4).  NIS score, Charlson score and CRP 167 
were not associated with readmission to hospital within 30 days, and these results did not change when 168 
the analysis was limited to unplanned readmissions only (data not shown).   169 
 170 
Table 3. Impact of variables on risk of increasing the length of hospital admission (length of stay, LOS)  171 
Predictor variables  Regression co-efficient (β) 
 
Incident rate ratio 
(eβ) and 95% 
confidence interval 
p 
Albumin concentration (g/L) -0.72 0.93   (0.92 – 0.94) <0.001 
C reactive protein (mg/L) 0.002 1.002  (1.001 – 1.002) <0.001 
Nutrition Impact Symptoms (NIS) score 0.019 1.019  (1.007 – 1.031) 0.002 
Charlson Comorbidity Index -0.05 0.95   ( 0.93 – 0.98) <0.001 
 172 
Table 4 – Multivariable logistic regression for factors related to hospital readmission within 30 days  173 
Predictor variables Odds ratio (β) 95% Confidence Interval p 
Unplanned admission 4.97 1.36 – 18.05 0.02 
Serum albumin 1.09 1.01 – 1.19 0.04 
Length of stay (LOS) 1.05 1.01 – 1.09 0.02 
 174 
Inter-Rater Reliability 175 
There was no difference in the total NIS score between measurers in 37% of cases. The mean 176 
difference between repeated NIS scores was 0.53 ± 2.81 (mean ± SD).  The Intra-class correlation 177 
coefficient was 0.74 (95% CI 0.57 - 0.85), indicating moderate reliability between users. 178 
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 179 
Discussion 180 
This study established that the NIS score is a valid nutrition screening tool to assess malnutrition risk in 181 
patients admitted to nephrology wards.  Concurrent, clinical and predictive validity were demonstrated 182 
through comparison to the SGA global rating of nutritional status, and by association with CRP, and 183 
increased risk of longer LOS, respectively.  184 
 185 
Compared with SGA, the concurrent validity was deemed to be at its highest with an NIS score of ≥3.  186 
This NIS score cut-off is higher than that selected in a previous investigation involving 213 187 
haemodialysis outpatients, which found that a NIS score of ≥2 was most effective at detecting 188 
malnutrition risk (16).  Median NIS scores in the well-nourished and malnourished groups were 1.0 and 189 
3.5 points lower, respectively, than the median scores in the present study, and less than a quarter of 190 
patients were classified as malnourished, indicating that when malnutrition risk is lower, the threshold 191 
for detection with a nutrition screening tool is also lower, in order to maximise sensitivity.  Together, 192 
these studies demonstrate the flexibility of the NIS score as a screening tool across different setting in 193 
patients with CKD, and also the importance of validating nutrition screening tools within the intended 194 
patient population. 195 
 196 
A nutrition screening tool should have a high level of sensitivity to detect malnutrition, to reduce the 197 
risk of failing to detect malnutrition risk in a malnourished patient (false negative result) (10).  An NIS 198 
score ≥3 had a sensitivity of 89%, demonstrating a far superior ability to detect malnutrition risk in 199 
patients with kidney disease than the MUST and MST tools; which were shown to have sensitivities of 200 
54% and 49% compared to SGA respectively (2).  With a specificity of 65%, the NIS score at a cut-off 201 
of ≥3 was relatively effective at identifying well-nourished patients, with similar specificity to the MST 202 
(18), although it does carry a reasonably high rate of false positive results.  More recently, another 203 
nutrition screening tool, the R-NST was developed specifically for renal inpatients (1).  The R-NST is 204 
more complex than the NIS score, and includes biochemical parameters alongside nutrition impact 205 
symptoms and weight loss history.  The R-NST demonstrated high sensitivity (97%) and moderately 206 
high specificity (74.4%), compared to SGA.  However in the reliability and feasibility phase of the study, 207 
the R-NST tool had low levels of completion by clinical staff due to the time taken to calculate 6-208 
month weight change, and extract the clinical data from the electronic medical records. Reliability was 209 
difficult to measure due to the very low completion rate for nursing staff (1), Together these results 210 
indicate that the R-NST  may have limited translational capacity for use in clinical practice.      211 
 212 
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This study is the first investigation to show that the NIS score is associated with LOS, an indicator of 213 
morbidity in patients with kidney disease (19), thus demonstrating a degree of predictive validity of the 214 
NIS score.  The NIS score has also previously been shown to predict long term clinical outcomes in 215 
patients on maintenance haemodialysis, as an NIS score of ≥2 was associated with a higher risk of 216 
mortality, whereas the SGA global rating was not (16). 217 
 218 
The NIS score had moderate inter-rater reliability, with an ICC of 0.74, and identical NIS scores were 219 
reported between assessors in 37% of patients.  Whilst this is less than ideal, it is significantly higher 220 
than the agreement between assessors using the R-NST, where there same score was achieved in the 221 
repeated measure in only 8% of cases (1).  Reliability of nutritional assessment using SGA can also be 222 
limited, with only fair inter-rater reliability between assessors following completion of an online training 223 
package (20).  The research team provided brief training to clinical assessors before determining the 224 
NIS score. Between-user differences might be minimised by introducing more in-depth training for all 225 
assessors, where measurers would be expected to demonstrate competency before using the NIS score 226 
in practice.  227 
 228 
The limitations of this study are also acknowledged.  In each assessment, the NIS and the SGA were 229 
undertaken by the same researcher in a single session, so blinding the researchers to the outcomes of 230 
the individual components was not possible.  However, as the study was conducted in three different 231 
time periods with different researchers, the robustness of the tool across users and over time is 232 
demonstrated.  There are several advantages of using the NIS score as a nutrition screening tool in 233 
preference to other tools.  The NIS score does not require measurement of body weight, knowledge of 234 
oedema free weight or previous weight loss.  The NIS score also has no biochemical parameters 235 
included, so it can be quickly and easily completed at the bedside.  Furthermore, the NIS score can 236 
identify the main factors impacting on food intake early during hospitalisation and can thus inform 237 
subsequent interventions to improve nutritional status (16).  As the NIS score identifies specific factors 238 
relating to malnutrition risk, it guides the choice of clinical intervention.  Symptoms such as dry mouth, 239 
taste changes, nausea, vomiting and constipation can all be treated clinically, whilst swallowing 240 
problems, feeling full quickly and fatigue require specific nutritional interventions.  241 
 242 
The outcomes of this study support the use of the NIS score as a nutrition screening tool for 243 
hospitalised patients on nephrology wards, adding to previous findings supporting its use in 244 
haemodialysis outpatients.  Concurrent, predictive and clinical validity were demonstrated against the 245 
SGA global rating of nutritional status, and the reliability between users was moderate.  Future research 246 
into the use of the NIS as a nutrition screening tool should focus on the effect of training and nursing 247 
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involvement in clinical implementation and the effect on longer-term clinical outcomes such as mortality, and 248 
patient focused outcomes such as quality of life, and discharge with maintained or improved functional capacity. 249 
 250 
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